$PFX
PhenixFIN Corp Stock $pfx

$pfx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024011611 Filed on February 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$571.3K	$1.709M	$1.649M
YoY Change	-88.37%	3.65%	-47.38%
Cost Of Revenue	$1.567M	$1.542M	$1.233M
YoY Change	13.44%	25.05%	-17.11%
Gross Profit	$3.092M	$4.180M	$3.470M
YoY Change	-12.44%	20.45%	110.87%
Gross Profit Margin	541.12%	244.58%	210.48%
Selling, General & Admin	$2.520M	$2.471M	$1.821M
YoY Change	43.49%	35.65%	26.01%
% of Gross Profit	81.52%	59.11%	52.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.520M	$94.00K	$1.821M
YoY Change	43.49%	-94.84%	26.01%
Operating Profit	$571.3K	$4.086M	$1.649M
YoY Change	-67.8%	147.81%	723.88%
Interest Expense	$1.567M	$1.542M	$1.203M
YoY Change	-68.24%	28.18%	-75.44%
% of Operating Profit	274.28%	37.74%	72.97%
Other Income/Expense, Net	$200.0K	$200.0K	$200.0K
YoY Change	0.0%	0.0%
Pretax Income	$5.372M	$4.534M	$3.952M
YoY Change	-19.91%	14.72%	-17.72%
Income Tax
% Of Pretax Income
Net Earnings	$5.372M	$871.0K	$3.952M
YoY Change	-19.91%	-77.96%	-17.72%
Net Earnings / Revenue	940.33%	50.97%	239.7%
Basic Earnings Per Share	$2.62	$2.19	$1.88
Diluted Earnings Per Share	$2.62	$2.19	$1.88
COMMON SHARES
Basic Shares Outstanding	2.060M shares	2.073M shares	2.101M shares
Diluted Shares Outstanding	2.049M shares	2.073M shares	2.101M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.12M	$12.17M	$17.65M
YoY Change	77.67%	-31.04%	-70.27%
Cash & Equivalents	$19.10M	$12.20M	$17.70M
Short-Term Investments
Other Short-Term Assets	$132.3K	$132.3K	$384.6K
YoY Change	6.41%	-65.6%
Inventory
Prepaid Expenses
Receivables	$920.8K	$1.400M	$1.713M
Other Receivables		$660.3K
Total Short-Term Assets	$25.75M	$14.37M	$20.72M
YoY Change	109.72%	-30.67%	-67.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$385.1K	$417.2K	$478.6K
YoY Change	-13.38%	-12.83%	-20.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$220.0M	$222.2M	$183.3M
YoY Change	9.98%	21.25%	4.49%
Other Assets	$1.174M	$615.6K	$1.054M
YoY Change	38.35%	-41.62%
Total Long-Term Assets	$221.9M	$223.5M	$184.7M
YoY Change	10.06%	21.02%	4.54%
TOTAL ASSETS
Total Short-Term Assets	$25.75M	$14.37M	$20.72M
Total Long-Term Assets	$221.9M	$223.5M	$184.7M
Total Assets	$247.7M	$237.8M	$205.4M
YoY Change	15.78%	15.81%	-14.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.843M	$1.615M	$1.042M
YoY Change	473.97%	54.99%	-91.38%
Accrued Expenses	$1.085M	$1.116M	$1.038M
YoY Change	-7.44%	7.5%	5.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.003M	$2.804M	$2.148M
YoY Change	152.37%	30.51%	-83.73%
LONG-TERM LIABILITIES
Long-Term Debt	$84.42M	$84.34M	$78.07M
YoY Change	7.03%	8.03%	0.55%
Other Long-Term Liabilities	$0.00	$0.00	$473.0K
YoY Change	-100.0%	-100.0%	18.35%
Total Long-Term Liabilities	$84.42M	$84.34M	$78.54M
YoY Change	6.57%	7.38%	0.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.003M	$2.804M	$2.148M
Total Long-Term Liabilities	$84.42M	$84.34M	$78.54M
Total Liabilities	$93.42M	$87.14M	$80.69M
YoY Change	12.85%	8.0%	-12.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$538.2M	-$543.6M	-$550.6M
YoY Change		-1.28%
Common Stock	$692.5M	$694.3M	$675.3M
YoY Change		2.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares			2.305K shares
Shareholders Equity	$154.3M	$150.7M	$124.7M
YoY Change
Total Liabilities & Shareholders Equity	$247.7M	$237.8M	$205.4M
YoY Change	15.78%	15.81%	-14.66%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	$5.372M	$871.0K	$3.952M
YoY Change	-19.91%	-77.96%	-17.72%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$8.959M	$6.754M	-$4.801M
YoY Change	-234.79%	-240.67%	-51.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$104.5K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.009M	-$568.6K	-$312.5K
YoY Change	723.29%	81.93%	138.68%
NET CHANGE
Cash From Operating Activities	8.959M	$6.754M	-$4.801M
Cash From Investing Activities
Cash From Financing Activities	-2.009M	-$568.6K	-$312.5K
Net Change In Cash	6.950M	$6.186M	-$5.114M
YoY Change	-200.86%	-220.96%	-49.13%
FREE CASH FLOW
Cash From Operating Activities	$8.959M	$6.754M	-$4.801M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments		usd
CY2022Q4	pfx	Weighted Average Diluted Earnings Per Share WeightedAverageDilutedEarningsPerShare	1.88
CY2023Q4	pfx	Weighted Average Diluted Earnings Per Share WeightedAverageDilutedEarningsPerShare	2.19
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2072694	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2100876	shares
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	1-35040
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	445 Park Avenue
CY2023Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	10th Floor
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q4	dei	City Area Code CityAreaCode	(212)
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	859-0390
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2060490	shares
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	222221652	usd
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	226460691	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12173975	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1400137	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	971115	usd
CY2023Q4	us-gaap	Dividends Receivable DividendsReceivable	243302	usd
CY2023Q3	us-gaap	Dividends Receivable DividendsReceivable	161479	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	31425	usd
CY2023Q4	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	132295	usd
CY2023Q3	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	199019	usd
CY2023Q4	pfx	Due From Affiliates Amount DueFromAffiliatesAmount	417014	usd
CY2023Q3	pfx	Due From Affiliates Amount DueFromAffiliatesAmount	409214	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	615571	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	833000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	637276	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	699124	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	3940175	usd
CY2023Q4	us-gaap	Assets Assets	237841222	usd
CY2023Q3	us-gaap	Assets Assets	239693465	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1605256	usd
CY2023Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1688835	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	84336685	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	84253106	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1615180	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3066984	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	721341	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	690398	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	394364	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	432698	usd
CY2023Q4	pfx	Administrator Expenses Payable AdministratorExpensesPayable	72852	usd
CY2023Q3	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased	4123059	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	421685	usd
CY2023Q4	us-gaap	Liabilities Liabilities	87140422	usd
CY2023Q3	us-gaap	Liabilities Liabilities	92987930	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2060490	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2073713	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2061	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2074	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	694273678	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	694812239	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-543574939	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-548108778	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	150700800	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	237841222	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	239693465	usd
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	73.14
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2023Q4	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	2682143	usd
CY2022Q4	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	1916041	usd
CY2023Q4	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	90674	usd
CY2022Q4	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	106187	usd
CY2023Q4	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	455692	usd
CY2022Q4	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	198453	usd
CY2022Q4	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	89743	usd
CY2023Q4	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	286238	usd
CY2022Q4	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	194627	usd
CY2023Q4	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments	149967	usd
CY2023Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	3664714	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	2505051	usd
CY2023Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2013726	usd
CY2022Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2032358	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
CY2023Q4	us-gaap	Net Investment Income NetInvestmentIncome	1708902	usd
CY2023Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	229804	usd
CY2023Q4	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	41108	usd
CY2022Q4	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	92226	usd
CY2023Q4	us-gaap	Fee Income FeeIncome	2108	usd
CY2022Q4	us-gaap	Fee Income FeeIncome	73599	usd
CY2023Q4	us-gaap	Other Income OtherIncome	22	usd
CY2023Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	5721678	usd
CY2022Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4703234	usd
CY2023Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1542061	usd
CY2022Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1233176	usd
CY2023Q4	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1424992	usd
CY2022Q4	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	857533	usd
CY2023Q4	us-gaap	Professional Fees ProfessionalFees	357554	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	347917	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	325061	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	219977	usd
CY2023Q4	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	187500	usd
CY2022Q4	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	194000	usd
CY2023Q4	us-gaap	General Insurance Expense GeneralInsuranceExpense	97756	usd
CY2022Q4	us-gaap	General Insurance Expense GeneralInsuranceExpense	124084	usd
CY2023Q4	pfx	Administrative Services Expense AdministrativeServicesExpense	77852	usd
CY2022Q4	pfx	Administrative Services Expense AdministrativeServicesExpense	77884	usd
CY2023Q4	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4012776	usd
CY2022Q4	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3054571	usd
CY2023Q4	us-gaap	Net Investment Income NetInvestmentIncome	1708902	usd
CY2022Q4	us-gaap	Net Investment Income NetInvestmentIncome	1648663	usd
CY2023Q4	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	229804	usd
CY2022Q4	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	13448	usd
CY2023Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	229804	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13448	usd
CY2023Q4	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	1364243	usd
CY2022Q4	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	1523099	usd
CY2023Q4	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	2431263	usd
CY2022Q4	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	715537	usd
CY2023Q4	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	-1200373	usd
CY2022Q4	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	51169	usd
CY2023Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2595133	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2289805	usd
CY2023Q4	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	2824937	usd
CY2022Q4	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	2303253	usd
CY2023Q4	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	4533839	usd
CY2022Q4	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	3951916	usd
CY2023Q4	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	2.19
CY2022Q4	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	1.88
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2072694	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2100876	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	120845408	usd
CY2022Q4	us-gaap	Net Investment Income NetInvestmentIncome	1648663	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13448	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2289805	usd
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	104519	usd
CY2022Q4	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	3847397	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	124692805	usd
CY2023Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2595133	usd
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	538574	usd
CY2023Q4	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	3995265	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	150700800	usd
CY2023Q4	pfx	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	4533839	usd
CY2022Q4	pfx	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	3951916	usd
CY2023Q4	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	22052279	usd
CY2022Q4	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	19188416	usd
CY2023Q4	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	14290362	usd
CY2022Q4	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	6931516	usd
CY2023Q4	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	240641	usd
CY2022Q4	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	195930	usd
CY2023Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	457300	usd
CY2022Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	72247	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	83579	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	103192	usd
CY2023Q4	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	91848	usd
CY2022Q4	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	30431	usd
CY2023Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	229804	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13448	usd
CY2023Q4	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	2595133	usd
CY2022Q4	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	2289805	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	429022	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	985314	usd
CY2023Q4	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	7800	usd
CY2022Q4	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	29058	usd
CY2023Q4	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold	-3940175	usd
CY2023Q4	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	81823	usd
CY2022Q4	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	287808	usd
CY2023Q4	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-31425	usd
CY2022Q4	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-36992	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-66724	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-104519	usd
CY2023Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-217429	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-138264	usd
CY2023Q4	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-4123059	usd
CY2022Q4	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-16550000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1451804	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-998141	usd
CY2023Q4	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	-72852	usd
CY2022Q4	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	6644	usd
CY2023Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	30943	usd
CY2023Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-421685	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	146919	usd
CY2023Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-38334	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-37682	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6754326	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4696944	usd
CY2023Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	30000	usd
CY2022Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	312523	usd
CY2023Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	538574	usd
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	104519	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-568574	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-417042	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6185752	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5113986	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12173975	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17654080	usd
CY2023Q4	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1319852	usd
CY2022Q4	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1099553	usd
CY2023Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	10000000	shares
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates in the Preparation of Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12200000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6000000	usd
CY2023Q4	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no material claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.</p>
CY2023Q4	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Recognition</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis. Discounts and premiums to par value on investments purchased are accreted and amortized into interest income over the life of the respective investment. Loan origination fees, original issue discount (“OID”) and market discounts or premiums are capitalized and amortized into interest income using the effective interest method or straight-line method, as applicable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is recorded on the accrual basis to the extent such amounts are expected to be collected. PIK interest is not accrued if the Company does not expect the issuer to be able to pay all principal and interest when due. For the three months ended December 31, 2023 and 2022, the Company earned approximately $0.2 million and $0.2 million in PIK interest, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amendment and transaction break-up fees associated with investments in portfolio companies are recognized as income when we become entitled to such fees. Prepayment penalties received by the Company for debt instruments paid back to the Company prior to the maturity date are recorded as income upon repayment of debt. Administrative agent fees received by the Company are capitalized as deferred revenue and recorded as fee income when the services are rendered. For the three months ended December 31, 2023 and 2022, fee income was less than $0.1 million and approximately $0.1 million, respectively (see Note 9).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investment transactions are accounted for on a trade date basis. Realized gains or losses on investments are measured by the difference between the net proceeds from the disposition and the amortized cost basis of investment using the specific identification method, without regard to unrealized gains or losses previously recognized. No losses relating to restructuring transactions occurred during the three months ended December 31, 2023 and 2022. <span>The Company reports changes in fair value of investments as net unrealized appreciation/(depreciation) on investments in the Consolidated Statements of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management reviews all loans that become 90 days or more past due on principal or interest or when there is reasonable doubt that principal or interest will be collected for possible placement on management’s designation of non-accrual status. Interest receivable is analyzed regularly and may be reserved against when deemed not collectible. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At December 31, 2023, certain investments in four portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $8.9 million, or 4.0% of the fair value of our portfolio. At September 30, 2023, certain investments in four portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $6.5 million, or 2.9% of the fair value of our portfolio.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q4	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	200000	usd
CY2022Q4	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	200000	usd
CY2023Q4	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	8900000	usd
CY2023Q4	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.04	pure
CY2023Q3	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	6500000	usd
CY2023	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.029	pure
CY2023Q4	pfx	Percentage Of Investment Company Taxable Income PercentageOfInvestmentCompanyTaxableIncome	0.90	pure
CY2023Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
CY2023Q4	pfx	Distributable Ordinary Income Percentage DistributableOrdinaryIncomePercentage	0.98	pure
CY2023Q4	pfx	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.982	pure
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	22900000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22900000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23100000	usd
CY2023Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as our borrowers, and those for which market yields are observable increase materially.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately. </p>
CY2023Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	228600	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206500	usd
CY2023Q4	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	22149000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	222222000	usd
CY2023Q4	pfx	Investment Owned Percentages Of Net Assets InvestmentOwnedPercentagesOfNetAssets	1	pure
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	226461000	usd
CY2023Q3	pfx	Investment Owned Percentages Of Net Assets InvestmentOwnedPercentagesOfNetAssets	1	pure
CY2023Q4	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	222222000	usd
CY2023Q4	pfx	Investment Owned Percentage Of Net Assets InvestmentOwnedPercentageOfNetAssets	1	pure
CY2023Q3	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	226461000	usd
CY2023Q3	pfx	Investment Owned Percentage Of Net Assets InvestmentOwnedPercentageOfNetAssets	1	pure
CY2023Q4	us-gaap	Investment Income Net InvestmentIncomeNet	965000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	4385000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	94000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	815000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	871000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3570000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	165316000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	14512000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-16654000	usd
CY2023Q4	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	266000	usd
CY2023Q4	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	479000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	163919000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	146675000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	7182000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-18297000	usd
CY2022Q4	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	-34000	usd
CY2022Q4	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	-185000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	135341000	usd
CY2023Q4	pfx	Net Change In Unrealized Gainloss NetChangeInUnrealizedGainloss	2100000	usd
CY2022Q4	pfx	Net Change In Unrealized Gainloss NetChangeInUnrealizedGainloss	2300000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	163919000	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	165316000	usd
CY2017Q3	pfx	Membership Interest Percentage MembershipInterestPercentage	0.05	pure
CY2017Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	2400000	usd
CY2023Q4	pfx	Asset Coverage Percentage With No Approval AssetCoveragePercentageWithNoApproval	2	pure
CY2023Q4	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.754	pure
CY2023Q3	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.707	pure
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	79058000	usd
CY2023Q4	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	85942000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	84337000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	79801000	usd
CY2023Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	79058000	usd
CY2023Q3	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	85942000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	84253000	usd
CY2023Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	77547000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q4	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	50000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
CY2023	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.029	pure
CY2023Q4	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
CY2023Q4	us-gaap	Line Of Credit Facility Borrowing Capacity Description LineOfCreditFacilityBorrowingCapacityDescription	the Company borrowed $23.2 million under the Credit Facility and used these proceeds to redeem $22.6 million in aggregate principal amount of the issued and outstanding 2023 Notes, comprising all issued and outstanding 2023 Notes. The 2023 Notes were redeemed at 100% of their principal amount, plus accrued and unpaid interest thereon from September 30, 2022 through, but excluding January 17, 2023 (the “Redemption Date”).
CY2022Q4	pfx	Aggregate Principal Amount AggregatePrincipalAmount	22521800	usd
CY2022Q4	pfx	Percentage Of Principal Amount PercentageOfPrincipalAmount	1	pure
CY2023Q4	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	598000	usd
CY2023Q4	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	14000	usd
CY2023Q4	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	92000	usd
CY2022Q4	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	30000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	84000	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	103000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	1542000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	1233000	usd
CY2023Q4	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	85942000	usd
CY2022Q4	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	80022000	usd
CY2023Q4	pfx	Accrual Amount AccrualAmount	304800	usd
CY2022Q4	pfx	Accrual Amount AccrualAmount	0	usd
CY2023Q4	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	2638000	usd
CY2023	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	3375000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease commenced September 1, 2021 and expires November 30, 2026.
CY2023Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2023Q3	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2023Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2023Q4	pfx	Other Fees Income OtherFeesIncome	2000	usd
CY2022Q4	pfx	Other Fees Income OtherFeesIncome	74000	usd
CY2023Q4	pfx	Fee Income Total FeeIncomeTotal	2000	usd
CY2022Q4	pfx	Fee Income Total FeeIncomeTotal	74000	usd
CY2023Q4	us-gaap	Other Expenses OtherExpenses	200000	usd
CY2022Q4	us-gaap	Other Expenses OtherExpenses	200000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4534000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	3952000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2072694	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2100876	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.19
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.88
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
CY2023Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.82
CY2022Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.78
CY2023Q4	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	0.11
CY2022Q4	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	0.01
CY2023Q4	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	1.26
CY2022Q4	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	1.09
CY2023Q4	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	2.19
CY2022Q4	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.88
CY2023Q4	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.2
CY2022Q4	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.01
CY2023Q4	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.2
CY2022Q4	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.01
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	73.14
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	59.38
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	150700800	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	124692805	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2060490	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2099824	shares
CY2023Q4	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	42.25
CY2022Q4	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	31.05
CY2023Q4	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.1148	pure
CY2022Q4	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	-0.1098	pure
CY2023Q4	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0265	pure
CY2022Q4	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0318	pure
CY2023Q4	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.068	pure
CY2022Q4	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.0375	pure
CY2023Q4	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0478	pure
CY2022Q4	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0128	pure
CY2023Q4	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1123	pure
CY2022Q4	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0238	pure
CY2023Q4	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0015	pure
CY2022Q4	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0156	pure
CY2023Q4	pfx	Average Debt Outstanding AverageDebtOutstanding	85941941	shares
CY2022Q4	pfx	Average Debt Outstanding AverageDebtOutstanding	80021800	shares
CY2023Q4	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	41.46
CY2022Q4	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	38.09
CY2023Q4	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2754	usd
CY2022Q4	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2597	usd
CY2023Q4	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	28441941	usd
CY2022Q4	pfx	Supplemental Data2023 Note SupplementalData2023Note	25.1
CY2023Q4	pfx	Supplemental Data2028 Note SupplementalData2028Note	22.54
CY2022Q4	pfx	Supplemental Data2028 Note SupplementalData2028Note	23.55
CY2023Q4	pfx	Asset Coverage Of Indebtedness AssetCoverageOfIndebtedness	1000	usd
CY2023Q4	us-gaap	Investment Company Senior Security Stock Asset Coverage Ratio InvestmentCompanySeniorSecurityStockAssetCoverageRatio	2.754	pure
CY2023Q4	us-gaap	Investment Company Senior Security Indebtedness Asset Coverage Ratio InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio	2	pure
CY2021Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	663219	shares
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	26300000	usd
CY2021Q1	pfx	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.243	pure
CY2021Q1	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	8700000	usd
CY2023Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	39.62
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	663219	shares
CY2023Q4	pfx	Stock Repurchased And Retired During Period Values StockRepurchasedAndRetiredDuringPeriodValues	26276060	usd
CY2023Q4	pfx	Stock Transferred To Treasury Stock StockTransferredToTreasuryStock	1848	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	125	shares
CY2023Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable		usd
CY2023Q4	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased		usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2022Q4	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments		usd
CY2023Q4	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments		usd
CY2022Q4	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments		usd
CY2023Q4	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments		usd
CY2022Q4	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments		usd
CY2022Q4	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold		usd
CY2022Q4	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable		usd
CY2023Q4	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable		usd
CY2022Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
CY2023Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
CY2022Q4	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings		usd
CY2022Q4	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
CY2023Q4	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
CY2022Q4	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
CY2023Q4	pfx	Administrative Agent Fee Income AdministrativeAgentFeeIncome		usd
CY2022Q4	pfx	Administrative Agent Fee Income AdministrativeAgentFeeIncome		usd
CY2023Q4	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2022Q4	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2072694	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2100876	shares
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.88
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.19
CY2023Q4	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax
CY2022Q4	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax
CY2022Q4	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility		usd
CY2023Q4	pfx	Supplemental Data2023 Note SupplementalData2023Note
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001490349

Files In Submission

Name	View Source	Status
0001213900-24-011611-index-headers.html	Edgar Link	pending
0001213900-24-011611-index.html	Edgar Link	pending
0001213900-24-011611.txt	Edgar Link	pending
0001213900-24-011611-xbrl.zip	Edgar Link	pending
f10q1223ex31-1_phenixfin.htm	Edgar Link	pending
f10q1223ex31-2_phenixfin.htm	Edgar Link	pending
f10q1223ex32-1_phenixfin.htm	Edgar Link	pending
f10q1223_phenixfin.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pfx-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pfx-20231231_cal.xml	Edgar Link	unprocessable
pfx-20231231_def.xml	Edgar Link	unprocessable
pfx-20231231_lab.xml	Edgar Link	unprocessable
pfx-20231231_pre.xml	Edgar Link	unprocessable
f10q1223_phenixfin_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PFX
PhenixFIN Corp Stock $pfx

2024 Q1 Form 10-Q Financial Statement

#000121390024011611 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX PhenixFIN Corp Stock $pfx

2024 Q1 Form 10-Q Financial Statement

#000121390024011611 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX
PhenixFIN Corp Stock $pfx